Bioabsorbable Stents Market Outlook for 2023 to 2033

The global bioabsorbable stents market size is estimated to clock a valuation of US$ 253.9 million by 2033. Our pharmaceutical experts opine that bioabsorbable stent suppliers can expect a CAGR of 4% through 2033, with a present valuation of US$ 171.8 million in 2023.

Attributes Details
Bioabsorbable Stents Market Size, 2022 US$ 167.7 million
Bioabsorbable Stents Market Size, 2023 US$ 171.8 million
Bioabsorbable Stents Market Size, 2033 US$ 253.9 million
Value CAGR (2023 to 2033) 4%

Trend Analysis of Bioabsorbable Stents Market

  • The techniques for stent development are undergoing significant transformation. With the presence of an exhaustive range of manufacturing modalities, manufacturers are predicted to observe significant opportunities in the time ahead. At present, there are five techniques to manufacture stents, such as etching laser cutting, electroforming, micro-electro, discharge machining, and die-casting.
  • 3D printing technology has attracted significant adoption in recent years. This can be attributed to the incapability of biodegradable stent materials to be processed with traditional methods, which has given a lot of attention to biological 3D printing technology.
  • Significant opportunities available in emerging economies like China are coaxing manufacturers to shift their base from developed markets and concentrate their resources to gain the most from these burgeoning markets.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance of Bioabsorbable Stents Market Vs. Forecast Outlook

Attributes Details
Bioabsorbable Stents Market Size (2018) US$ 153.40 million
Bioabsorbable Stents Market Size (2022) US$ 167.7 million
Bioabsorbable Stents Market (CAGR 2018 to 2022) 2.2%

The bioabsorbable stents market accounts for a negligible share of the global stents market. However, with surging innovations and advancements in bioabsorbable stents, the market is expected to elevate at a steady pace.

As per the latest market records, the market observed a 2.2% CAGR from 2018 to 2022. The Initial generation of stents, called BMS, is composed of cobalt-chromium, tantalum, platinum-iridium alloys, nitinol, and stainless steel. However, these stents have been reworked to alleviate the number of problems or maintenance as a foreign body.

After consideration, coated stents, biodegradable stents, and drug-eluting stents came into the picture. The restenosis rate decreased as bare metal stents saw broader adoption.

Advancements in stents have led to the development of bioabsorbable stents, which can weaken and break down into natural by-products after completing their primary goal of offering judicious support for diseased lesions. Due to quick implantation, the decomposition of bioabsorbable stents is making them reachable to patients of all ages, especially children, boosting the adoption in the next decade.

Due to the widespread frequency of CVD, the demand for bioabsorbable stents is predicted to heighten owing to their efficiency and lowered adverse effects. The bioabsorbable stents market is expected to observe a CAGR of 4% through 2033.

Comparative View of Adjacent Bioabsorbable Stents Market

The global stents market has been witnessing significant growth since the historical period. Currently, in the stents market, several subcategories have emerged. Some of these subcategories include peripheral vascular stents, aortic stents grafts, non-vascular stents, stent graft balloon catheter, etc.

The in-depth market insights of aortic stents grafts demonstrate lowered morbidity with procedures including aortic stents grafts. Since procedural safety and successful outcomes drive future adoption, FMI analysts have estimated a CAGR of 4.5% through 2033. FMI has also studied the revenue analysis of the peripheral vascular stents market, which is expected to gross revenue of US$ 5.3 billion in 2028.

The table below has compared the two markets, namely the non-vascular stents market and the stent graft balloon catheter market, alongside the bioabsorbable stents market. Based on CAGR, the stent graft balloon catheter market is expected to take precedence. Concerning revenue, the non-vascular stents market holds greater value than the other two markets.

Bioabsorbable Stents Market:

Attributes Bioabsorbable Stents Market
CAGR (2023 to 2033) 4%
Market Value (2023) US$ 171.8 million
Growth Factors
  • Growing CVD cases
  • Ongoing research in the field of bioabsorbable stents
Future Opportunities Emerging opportunities in emerging economies
Market Trends Advances in manufacturing techniques

Non-vascular Stents Market:

Attributes Non-vascular Stents Market
CAGR (2023 to 2033) 4.5%
Market Value (2023) US$ 1.26 billion
Growth Factors
  • Favorable government proposals
  • Surging demand from patients experiencing minimally invasive operations as a result of reduced costs and shortened methodology times
Future Opportunities Prolonged research and development in the market is creating a new opportunity for non-vascular stents
Market Trends Significant advancements in the material have facilitated the creation of custom-made stents for many conditions

Stent Graft Balloon Catheter Market:

Attributes Stent Graft Balloon Catheter Market
CAGR (2023 to 2033) 7%
Market Value (2023) US$ 980.03 million
Growth Factors
  • Surging rate of coronary artery diseases
  • Rising patients of atherosclerosis, the world over
  • Improving healthcare spending
Future Opportunities Increasing innovation in the product by key players
Market Trends Surging initiatives by government and non-government bodies to elevate knowledge about CVDs are expected to boost the sales of stent graft balloon catheters
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Country/ Region Value Share (2022)
North America 48.5%
Europe 27.6%
The United States 44.4%
Germany 9.9%
Japan 5.1%

The United States to Enjoy a Prominent Market Cut

The North America market accounted for a sizeable portion of the bioabsorbable stent market in 2022, accounting for 48.5% market share. The United States captures a prominent share in the region, recording a 44.4% value share globally. The market demand for bioabsorbable stents is being influenced not only by doctors, but also by hospital administrators, regulators, and other non-clinicians. This wider circle of influencers presents distinct goals to the table, including cost-effectiveness. This shift in dynamics suggests a change in individual outcomes to an emphasis on population-level usefulness, like an overall enhancement seen in a population for a certain level of spending.

Rivalry in the medical products industry is becoming more intense. Blockbuster categories like bioabsorbable coronary stents are gaining more manufacturers as they mature. As active participants find it harder to identify a high-impact scientific innovation in the market, relatively small firms are procuring market stakes by providing innovative business models at reduced prices. Higher price transparency facilitated by the surging use of tenders in the country is giving a competitive edge to low-cost participants.

Europe Paving the Way for the Success of Bioabsorbable Stents

Europe is another notable market for bioabsorbable stents. As per the latest market updates, the European bioabsorbable stent market is expected to account for around 27.6% value share in 2023. Germany is predicted to register a chief position in the region. Globally, Germany’s market share is expected to clock 9.9% in 2023. The United Kingdom, which is another key player in the region, is predicted to record a CAGR of 5.7% through 2033.

The region has been an active participant in the field of bioabsorbable stents. The region kickstarted the commercial use of bioresorbable stents by giving appropriate approvals. To be precise, in January 2011, the European CE mark permitted to Absorb, Abbott drug-eluting bioresorbable coronary stent. It was the first-ever bioresorbable stent to obtain regulatory approval the world over.

Fast forward to 2023, the bioresorbable devices still embody the future of coronary stents. Key players in the region are zeroing in on long-term research on the device, with the motive of enhancing the market scope and opportunities for the respective companies. A key example of this practice is Abbott Vascular. With this in mind, companies are expected to thrive in the Europe market.

Future of Bioabsorbable Stents in the Asia Pacific

The Asia Pacific market for bioabsorbable stents paints a promising picture. Core Asian markets like China and India represent a growth of 6.6% and 4.6% CAGR. Consequently, they attract key players to build or expand their base. Surging investments in healthcare and expanding middle classes in these countries are making them a haven for premium products.

Recently, these marketplaces are showing higher growth due to innovations in pricing mechanisms and purchasing processes. Medical product manufacturers in the market have been proactive in capturing the vast opportunities available.

To gain most of the current market scene, key players need to make up their minds about their go-to-market models, tiered portfolios, business development, implications for supply chain, differentiated offerings, M&A, and cost of goods sold. With this comprehensive outlook, they would be better equipped to chart the revenue-generating opportunities in Asia Pacific.

Explore the Competitive Status of Bioabsorbable Stents Providers in Japan

The area of medical research is constantly evolving and currently, it also encompasses bioresorbable stents and polymer-free stents. The Japan bioabsorbable stents industry is being propelled by the increasing acceptability of stents to treat coronary artery disease (CAD). According to the latest research by FMI analysts, the bioabsorbable stents market in Japan is forecast to acquire about 5.1% in 2023.

In the past, precisely in July 2016, Japan’s Ministry of Health, Labor, and Welfare (MHLW) permitted Abbott’s Absorb bioresorbable heart stent, making this then-unique medical instrument commercially available to treat patients of coronary artery disease in Japan.

In the present competitive scene, key players are strategically advancing in the Japan market using M&A, partnerships, collaborations, and product innovation, to gain greater market share.

Key Players in Australia Realize the Enhancements in the Clinical Outcomes by Using Coronary Stents

As per the recent analysis, the Australia market is thriving at a 6.2% CAGR through 2033. Significant untapped prospects in this landscape are fueling the market sales of bioabsorbable stents in the country. By working on improving the insufficiencies of coronary stents, key players can modify these devices to develop an optimized coronary stent. Additionally, the growing knowledge about the enhanced clinical outcomes in interventional cardiology with the use of coronary stents is expected to spur market growth.

Category-wise Insights

About 4/5th of Bioabsorbable Stents Sales to be Led by Coronary Artery Stents

Coronary artery stents account for a substantial share of 76.2% as of 2022. Numerous angioplasty operations drive demand for coronary stents. Angioplasty can relieve the symptoms of blocked arteries like shortness of breath and chest pains. Due to the high incidence rate of CVD, the selection of angioplasty is fueling the adoption of stent procedures. This is uplifting the demand for coronary artery stents due to their stability and efficacy in comparison to conventional stents.

Polymers-composed Bioabsorbable Stents are Gaining Traction

As per the latest market study, polymer-made bioabsorbable stents are acquiring significant market share in the global landscape. The segment is expected to obtain about 59.3% market share in 2023. Biodegradable (BIO) polymers are capable of reducing the occurrence of subsequent complications like mal-apposition, stent strut uncovering, thrombosis, and endothelial dysfunction. Advantages of using these stents include lowered inflammatory response and entire drug elution. Therefore, polymer materials are gaining significant attention for the development of bioabsorbable stents.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Strategies Maximized by the Key Players

Key players in the market are strategizing to enhance their product range and revise product patenting, to serve the clinical requirements of patients. Market participants release novel products and obtain regulatory approvals and licensing for distribution to improve their geographical presence.

Key Developments in the Market

  • In April 2023, BIOTRONIK reported a comprehensive commercial launch of the Orsiro Mission Drug-eluting stent system in Canada. This system is indicated for enhancing coronary luminal diameter in patients suffering from diabetes mellitus, and other diseases. Post its approval from Health Canada, the company is replacing Orsiro with its newest generation of Orsiro Mission.
  • In March 2021, Meril Life Sciences introduced indigenously studied and developed MeRes100, which is a thin-struct bioresorbable scaffold. These stents provide a substitute treatment option along with metallic stent implants.
  • In October 2021, Boston Scientific Corporation revealed optimistic results for the Eluvia™ Drug-Eluting Vascular Stent System throughout a late-breaking clinical trial presentation at the Vascular InterVentional Advances meeting in Las Vegas. The system showcases higher sustained clinical improvement and superior rates of primary patency.

Key Players in the Market

  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Medtronic Plc
  • Smith & Nephew Plc
  • Stryker Corporation
  • Wright Medical Group
  • KLS Martin
  • BIOTRONIK Ltd
  • Syntellix AG
  • Q3 Medical Devices Limited.
  • JW Medical Systems LTD
  • ORBUSNEICH MEDICAL
  • Abbott Vascular

Key Market Segments Covered in Bioabsorbable Stents Market Report

By Stents:

  • Coronary Artery Stents
  • Peripheral Artery Stents
  • Non-vascular Stents
    • Esophageal Stents
    • Billary Stents

By Material:

  • Metallic
  • Ceramic
  • Polymers
    • PGA
    • PLA
    • Co-Polymer

By Application:

  • Cardiovascular
  • Orthopedics
  • Cosmetic Surgery
  • General Surgery
  • Cranial
  • Others

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Bioabsorbable Stents Market?

The bioabsorbable stents are worth US$ 171.8 million in 2023.

What is the Growth Scope of the Bioabsorbable Stents Market?

The market is expected to expand at a CAGR of 4% through 2033.

Which Country is Expected to See Significant Uptake of Bioabsorbable Stents?

China is expected to see substantial consumption of bioabsorbable stents.

Which Product Type is Highly Preferred by End Users?

Coronary artery stents are a highly preferred product type by its end users.

Which Material Type is Sought-after in the Market?

Polymers are a sought-after material for bioabsorbable stents.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Stents

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Stents, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Stents, 2023 to 2033

        5.3.1. Coronary Artery Stents

        5.3.2. Peripheral Artery Stents

        5.3.3. Non-vascular Stents

            5.3.3.1. Esophageal Stents

            5.3.3.2. Billary Stents

    5.4. Y-o-Y Growth Trend Analysis By Stents, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Stents, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2023 to 2033

        6.3.1. Metallic

        6.3.2. Ceramic

        6.3.3. Polymers

            6.3.3.1. PGA

            6.3.3.2. PLA

            6.3.3.3. Co-Polymer

    6.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        7.3.1. Cardiovascular

        7.3.2. Orthopedics

        7.3.3. Cosmetic Surgery

        7.3.4. General Surgery

        7.3.5. Cranial

        7.3.6. Others

    7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Hospitals

        8.3.2. Specialty Clinics

        8.3.3. Ambulatory surgical Centers

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Stents

        10.2.3. By Material

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Stents

        10.3.3. By Material

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Stents

        11.2.3. By Material

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Stents

        11.3.3. By Material

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. U.K.

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Stents

        12.2.3. By Material

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Stents

        12.3.3. By Material

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Stents

        13.2.3. By Material

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Stents

        13.3.3. By Material

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Stents

        14.2.3. By Material

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Stents

        14.3.3. By Material

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Stents

        15.2.3. By Material

        15.2.4. By Application

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Stents

        15.3.3. By Material

        15.3.4. By Application

        15.3.5. By End User

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Stents

        16.2.3. By Material

        16.2.4. By Application

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Stents

        16.3.3. By Material

        16.3.4. By Application

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. U.S.

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Stents

            17.1.2.2. By Material

            17.1.2.3. By Application

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Stents

            17.2.2.2. By Material

            17.2.2.3. By Application

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Stents

            17.3.2.2. By Material

            17.3.2.3. By Application

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Stents

            17.4.2.2. By Material

            17.4.2.3. By Application

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Stents

            17.5.2.2. By Material

            17.5.2.3. By Application

            17.5.2.4. By End User

    17.6. U.K.

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Stents

            17.6.2.2. By Material

            17.6.2.3. By Application

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Stents

            17.7.2.2. By Material

            17.7.2.3. By Application

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Stents

            17.8.2.2. By Material

            17.8.2.3. By Application

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Stents

            17.9.2.2. By Material

            17.9.2.3. By Application

            17.9.2.4. By End User

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Stents

            17.10.2.2. By Material

            17.10.2.3. By Application

            17.10.2.4. By End User

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Stents

            17.11.2.2. By Material

            17.11.2.3. By Application

            17.11.2.4. By End User

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Stents

            17.12.2.2. By Material

            17.12.2.3. By Application

            17.12.2.4. By End User

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Stents

            17.13.2.2. By Material

            17.13.2.3. By Application

            17.13.2.4. By End User

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Stents

            17.14.2.2. By Material

            17.14.2.3. By Application

            17.14.2.4. By End User

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Stents

            17.15.2.2. By Material

            17.15.2.3. By Application

            17.15.2.4. By End User

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Stents

            17.16.2.2. By Material

            17.16.2.3. By Application

            17.16.2.4. By End User

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Stents

            17.17.2.2. By Material

            17.17.2.3. By Application

            17.17.2.4. By End User

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Stents

            17.18.2.2. By Material

            17.18.2.3. By Application

            17.18.2.4. By End User

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Stents

            17.19.2.2. By Material

            17.19.2.3. By Application

            17.19.2.4. By End User

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Stents

            17.20.2.2. By Material

            17.20.2.3. By Application

            17.20.2.4. By End User

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Stents

            17.21.2.2. By Material

            17.21.2.3. By Application

            17.21.2.4. By End User

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2022

            17.22.2.1. By Stents

            17.22.2.2. By Material

            17.22.2.3. By Application

            17.22.2.4. By End User

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2022

            17.23.2.1. By Stents

            17.23.2.2. By Material

            17.23.2.3. By Application

            17.23.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Stents

        18.3.3. By Material

        18.3.4. By Application

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Boston Scientific Corporation

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

                19.1.1.5.2. Product Strategy

                19.1.1.5.3. Channel Strategy

        19.1.2. Meril Life Sciences Pvt. Ltd.

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

                19.1.2.5.2. Product Strategy

                19.1.2.5.3. Channel Strategy

        19.1.3. Medtronic Plc

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

                19.1.3.5.2. Product Strategy

                19.1.3.5.3. Channel Strategy

        19.1.4. Smith & Nephew Plc

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

                19.1.4.5.2. Product Strategy

                19.1.4.5.3. Channel Strategy

        19.1.5. Stryker Corporation

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

                19.1.5.5.2. Product Strategy

                19.1.5.5.3. Channel Strategy

        19.1.6. Wright Medical Group

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

                19.1.6.5.2. Product Strategy

                19.1.6.5.3. Channel Strategy

        19.1.7. KLS Martin

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

                19.1.7.5.2. Product Strategy

                19.1.7.5.3. Channel Strategy

        19.1.8. BIOTRONIK Ltd

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

                19.1.8.5.2. Product Strategy

                19.1.8.5.3. Channel Strategy

        19.1.9. Syntellix AG

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

                19.1.9.5.2. Product Strategy

                19.1.9.5.3. Channel Strategy

        19.1.10. Q3 Medical Devices Limited.

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

                19.1.10.5.2. Product Strategy

                19.1.10.5.3. Channel Strategy

        19.1.11. JW Medical Systems LTD

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

                19.1.11.5.2. Product Strategy

                19.1.11.5.3. Channel Strategy

        19.1.12. ORBUSNEICH MEDICAL

            19.1.12.1. Overview

            19.1.12.2. Product Portfolio

            19.1.12.3. Profitability by Market Segments

            19.1.12.4. Sales Footprint

            19.1.12.5. Strategy Overview

                19.1.12.5.1. Marketing Strategy

                19.1.12.5.2. Product Strategy

                19.1.12.5.3. Channel Strategy

        19.1.13. Abbott Vascular

            19.1.13.1. Overview

            19.1.13.2. Product Portfolio

            19.1.13.3. Profitability by Market Segments

            19.1.13.4. Sales Footprint

            19.1.13.5. Strategy Overview

                19.1.13.5.1. Marketing Strategy

                19.1.13.5.2. Product Strategy

                19.1.13.5.3. Channel Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Aortic Stents Grafts Market

December 2021

REP-GB-865

September 2023

215 pages

Healthcare

Stent Graft Balloon Catheter Market

September 2024

REP-GB-1628

Upcoming

Healthcare

Coronary Stents Market

January 2020

REP-GB-1993

October 2022

206 pages

Healthcare

Non-Vascular Stents Market

February 2022

REP-GB-653

October 2022

315 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Bioabsorbable Stents Market